|
|
|
Insider
Information: |
Emster Kurt Von |
Relationship: |
Director |
City: |
|
State: |
|
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
7 |
|
Direct
Shares |
302,614 |
|
Indirect Shares
|
18,297,697 |
|
|
Direct
Value |
$5,616,334 |
|
|
Indirect Value
|
$163,387,068 |
|
|
Total
Shares |
18,600,311 |
|
|
Total
Value |
$169,003,402 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Rigel Pharmaceuticals Inc |
RIGL |
10% Owner |
2003-06-26 |
173,611 |
2004-02-19 |
4,350,516 |
Premium* |
|
Somaxon Pharmaceuticals, Inc. |
SOMX |
Director |
2013-03-06 |
0 |
2013-03-06 |
0 |
Premium* |
|
Crispr Therapeutics Ag |
CRSP |
Director |
2018-06-05 |
90,000 |
2018-12-18 |
1,171,268 |
Premium* |
|
Cymabay Therapeutics, Inc. |
CBAY |
|
2024-03-22 |
0 |
2023-09-29 |
18,406 |
Premium* |
|
Vaxcyte, Inc. |
PCVX |
Director |
2020-06-16 |
0 |
2020-06-16 |
4,168,718 |
Premium* |
|
Vera Therapeutics, Inc. |
VERA |
Director |
2021-05-17 |
17,828 |
2021-05-18 |
2,960,231 |
Premium* |
|
Amplitude Healthcare Acquisition... |
AMHCU |
Director |
2023-04-13 |
21,175 |
2021-09-24 |
5,628,558 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
108 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 5
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
RIGL |
Rigel Pharmaceuticals Inc |
10% Owner |
|
2003-06-26 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
4,340,278 |
|
- |
|
RIGL |
Rigel Pharmaceuticals Inc |
10% Owner |
|
2003-06-26 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
173,611 |
|
- |
|
AMHCU |
Amplitude Healthcare Acqu... |
Director |
|
2021-09-24 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
5,628,558 |
|
% |
|
CRSP |
Crispr Therapeutics Ag |
Director |
|
2017-08-01 |
4 |
AS |
$17.50 |
$4,620 |
I/I |
(264) |
2,276,822 |
0 |
- |
|
CRSP |
Crispr Therapeutics Ag |
Director |
|
2017-07-28 |
4 |
AS |
$17.65 |
$7,060 |
I/I |
(400) |
2,282,334 |
0 |
- |
|
SOMX |
Somaxon Pharmaceuticals, ... |
Director |
|
2008-12-31 |
4 |
A |
$0.00 |
$0 |
D/D |
543 |
543 |
0 |
- |
|
CBAY |
Cymabay Therapeutics, Inc... |
Director |
|
2018-06-05 |
4 |
S |
$12.51 |
$11,509 |
I/I |
(920) |
18,316 |
0 |
- |
|
CRSP |
Crispr Therapeutics Ag |
Director |
|
2018-06-05 |
4 |
S |
$12.51 |
$11,509 |
I/I |
(920) |
18,316 |
0 |
- |
|
CRSP |
Crispr Therapeutics Ag |
Director |
|
2017-08-21 |
4 |
AS |
$18.51 |
$23,138 |
I/I |
(1,250) |
2,080,140 |
0 |
- |
|
SOMX |
Somaxon Pharmaceuticals, ... |
Director |
|
2010-03-31 |
4 |
A |
$0.00 |
$0 |
D/D |
1,283 |
53,216 |
0 |
- |
|
SOMX |
Somaxon Pharmaceuticals, ... |
Director |
|
2012-09-05 |
4 |
S |
$0.29 |
$396 |
I/I |
(1,367) |
25,712 |
0 |
- |
|
CRSP |
Crispr Therapeutics Ag |
Director |
|
2017-06-22 |
4 |
AS |
$16.21 |
$24,753 |
I/I |
(1,527) |
2,600,287 |
0 |
- |
|
CRSP |
Crispr Therapeutics Ag |
Director |
|
2017-08-18 |
4 |
AS |
$18.53 |
$35,207 |
I/I |
(1,900) |
2,081,390 |
0 |
- |
|
CBAY |
Cymabay Therapeutics, Inc... |
Director |
|
2018-02-02 |
4 |
AS |
$12.11 |
$24,220 |
I/I |
(2,000) |
479,287 |
0 |
- |
|
CBAY |
Cymabay Therapeutics, Inc... |
Director |
|
2018-06-05 |
4 |
OE |
$5.75 |
$11,500 |
I/I |
2,000 |
19,236 |
0 |
- |
|
CRSP |
Crispr Therapeutics Ag |
Director |
|
2018-06-05 |
4 |
OE |
$5.75 |
$11,500 |
I/I |
2,000 |
19,236 |
0 |
- |
|
CRSP |
Crispr Therapeutics Ag |
Director |
|
2018-12-17 |
4 |
S |
$33.17 |
$99,797 |
I/I |
(3,009) |
1,234,193 |
0 |
- |
|
CRSP |
Crispr Therapeutics Ag |
Director |
|
2017-08-04 |
4 |
AS |
$18.50 |
$56,758 |
I/I |
(3,068) |
2,226,345 |
0 |
- |
|
SOMX |
Somaxon Pharmaceuticals, ... |
Director |
|
2006-09-11 |
4 |
S |
$14.00 |
$43,290 |
I/I |
(3,089) |
470,718 |
|
- |
|
SOMX |
Somaxon Pharmaceuticals, ... |
Director |
|
2013-03-06 |
4 |
D |
$0.00 |
$0 |
I/I |
(3,214) |
0 |
0 |
- |
|
SOMX |
Somaxon Pharmaceuticals, ... |
Director |
|
2009-09-30 |
4 |
A |
$0.00 |
$0 |
D/D |
3,886 |
43,137 |
0 |
- |
|
CRSP |
Crispr Therapeutics Ag |
Director |
|
2017-07-05 |
4 |
AS |
$16.26 |
$69,170 |
I/I |
(4,254) |
2,440,555 |
0 |
- |
|
CBAY |
Cymabay Therapeutics, Inc... |
Director |
|
2018-01-05 |
4 |
AS |
$10.21 |
$43,903 |
I/I |
(4,300) |
988,931 |
0 |
- |
|
CBAY |
Cymabay Therapeutics, Inc... |
Director |
|
2017-11-01 |
4 |
AS |
$9.25 |
$39,979 |
I/I |
(4,320) |
1,216,471 |
0 |
- |
|
CRSP |
Crispr Therapeutics Ag |
Director |
|
2017-07-31 |
4 |
AS |
$17.51 |
$91,871 |
I/I |
(5,248) |
2,277,086 |
0 |
- |
|
108 Records found
|
|
Page 1 of 5 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|